← 返回列表

@ycombinator: Astraea brings drugs to market faster by fully automating clinical trial biometrics, turning raw study data into CDISC-compliant datasets, T...

@ycombinator 3 信息等级 3 1 噪音/剔除;2 较弱;3 普通事实;4 重要行业动态;5 极重大事件。该分数是信息显著性,不是投资建议。 发布:2026-05-14T22:00 抓取:2026-05-15 04:03
🔗 原文链接
摘要

Y Combinator支持的Astraea公司宣布推出全自动临床试验生物统计工具,能将原始研究数据在数天内转换为CDISC兼容数据集和FDA就绪输出,加速药物上市进程。

客观事实
  • Astraea自动化临床试验生物统计流程
  • 将原始数据转换为CDISC兼容数据集和FDA就绪输出
Astraea CDISC FDA

原文

Astraea brings drugs to market faster by fully automating clinical trial biometrics, turning raw study data into CDISC-compliant datasets, TFLs, and FDA-ready outputs in days.

Congrats on the launch, @joshwqngsr and Sanmay!

https://t.co/0prLcgOdwd https://t.co/S9a8WwSVc5

likes: 40 | retweets: 5 | replies: 4 | views: 7067